We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+9.93%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
AUM
$177M
AUM Growth
+$18.7M
Cap. Flow
+$5.4M
Cap. Flow %
3.04%
Top 10 Hldgs %
18.89%
Holding
982
New
339
Increased
167
Reduced
226
Closed
62

Top Buys

Rank Stock Value
1
CTRA
Coterra Energy
CTRA
+$1.5M
2
ARE icon
Alexandria Real Estate Equities
ARE
+$1.48M
3
SON icon
Sonoco
SON
+$1.42M
4
R icon
Ryder
R
+$1.39M
5
AMT icon
American Tower
AMT
+$1.38M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$1.78M
2
IBM icon
IBM
IBM
+$1.56M
3
INGR icon
Ingredion
INGR
+$1.48M
4
ELV icon
Elevance Health
ELV
+$1.47M
5
MDT icon
Medtronic
MDT
+$1.21M

Sector Composition

Rank Sector Weight
1 Technology 20.99%
2 Real Estate 18.63%
3 Industrials 12.95%
4 Healthcare 10.2%
5 Consumer Staples 6.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNAP icon
551
Snap
SNAP
$9.3B
$4.89K ﹤0.01%
546
-2,019
-79% -$19.9K
LNN icon
552
Lindsay Corp
LNN
$1.17B
$4.89K ﹤0.01%
+30
New +$4.95K
ITW icon
553
Illinois Tool Works
ITW
$83.5B
$4.85K ﹤0.01%
22
+11
+100% +$2.34K
MTDR icon
554
Matador Resources
MTDR
$6.51B
$4.81K ﹤0.01%
+84
New +$5.3K
XRN
555
Chiron Real Estate Inc
XRN
$465M
$4.74K ﹤0.01%
+100
New +$4.52K
EWJ icon
556
iShares MSCI Japan ETF
EWJ
$22.7B
$4.74K ﹤0.01%
+87
New +$4.58K
ITCI
557
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$4.71K ﹤0.01%
89
-59
-40% -$2.96K
UCB
558
United Community Banks
UCB
$4.35B
$4.7K ﹤0.01%
+139
New +$5.04K
ACRS icon
559
Aclaris Therapeutics
ACRS
$866M
$4.69K ﹤0.01%
298
EWL icon
560
iShares MSCI Switzerland ETF
EWL
$2.23B
$4.65K ﹤0.01%
+111
New +$4.51K
CHRD icon
561
Chord Energy
CHRD
$7.62B
$4.51K ﹤0.01%
+33
New +$4.84K
CF icon
562
CF Industries
CF
$17.8B
$4.43K ﹤0.01%
+52
New +$5.28K
CNDT icon
563
Conduent
CNDT
$240M
$4.38K ﹤0.01%
1,082
-16,984
-94% -$65.1K
VSTO
564
DELISTED
Vista Outdoor Inc.
VSTO
$4.34K ﹤0.01%
178
EXC icon
565
Exelon
EXC
$46.2B
$4.32K ﹤0.01%
100
AGCO icon
566
AGCO
AGCO
$7.1B
$4.3K ﹤0.01%
+31
New +$3.82K
BG icon
567
Bunge Global
BG
$21.5B
$4.29K ﹤0.01%
+43
New +$4.13K
PFF icon
568
iShares Preferred and Income Securities ETF
PFF
$13.2B
$4.28K ﹤0.01%
140
FL
569
DELISTED
Foot Locker
FL
$4.27K ﹤0.01%
113
-338
-75% -$11.6K
EQC
570
DELISTED
Equity Commonwealth
EQC
$4.25K ﹤0.01%
+170
New +$4.35K
CUTR
571
DELISTED
Cutera, Inc.
CUTR
$4.25K ﹤0.01%
96
AZZ icon
572
AZZ Inc
AZZ
$4.63B
$4.18K ﹤0.01%
+104
New +$4.09K
CNXC icon
573
Concentrix
CNXC
$1.57B
$4.13K ﹤0.01%
31
-48
-61% -$5.83K
BKE icon
574
Buckle
BKE
$2.37B
$4.13K ﹤0.01%
+91
New +$3.67K
APPN icon
575
Appian
APPN
$2.54B
$4.1K ﹤0.01%
126

Similar funds

Truvestments Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Truvestments Capital held 982 positions worth $177M, up 12% from $159M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Truvestments Capital deployed $5.4M of net new capital in Q4 2022, opening 339 new positions and adding to 167 existing holdings. Its largest new stake was Coterra Energy: 54,452 shares worth $1.34M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Real Estate and Industrials.

On the sell side, the largest reduction was AbbVie, an estimated $1.78M trimmed.

  • Truvestments Capital's largest Q4 2022 buy was Coterra Energy: 54,452 shares worth $1.34M.
  • Truvestments Capital added most to Alexandria Real Estate Equities in Q4 2022, an estimated $1.48M increase.
  • Truvestments Capital's biggest Q4 2022 reduction was AbbVie, cutting an estimated $1.78M.
  • Truvestments Capital fully exited Twitter, Inc. in Q4 2022, selling an estimated $374K.
  • Truvestments Capital's ten largest holdings make up 19% of its $177M portfolio in Q4 2022.
  • Truvestments Capital opened 339 new positions and closed 62 in Q4 2022.
  • Truvestments Capital's portfolio value rose 12% quarter-over-quarter to $177M.

Based on Truvestments Capital's 13F filing for Q4 2022, filed 14 Feb 2023.